• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.医学研究委员会(MRC)呼吸困难量表在评估慢性阻塞性肺疾病患者残疾程度方面的实用性。
Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.
2
Stages of disease severity and factors that affect the health status of patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者的疾病严重程度阶段及影响其健康状况的因素。
Respir Med. 2000 Sep;94(9):841-6. doi: 10.1053/rmed.2000.0804.
3
Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评估临床方法分析
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091.
4
Analysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational study.慢性阻塞性肺疾病患者呼吸困难的纵向变化分析:一项观察性研究。
Respir Res. 2012 Sep 25;13(1):85. doi: 10.1186/1465-9921-13-85.
5
Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale.重度慢性阻塞性肺疾病患者肺康复的随机对照试验,按医学研究委员会呼吸困难量表分层
Eur Respir J. 1998 Aug;12(2):363-9. doi: 10.1183/09031936.98.12020363.
6
Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.用于测量慢性阻塞性肺疾病患者健康相关生活质量的疾病特异性问卷之间的鉴别特性比较。
Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):785-90. doi: 10.1164/ajrccm.157.3.9703055.
7
Development of an activity of daily living scale for patients with COPD: the Activity of Daily Living Dyspnoea scale.慢性阻塞性肺疾病患者日常生活活动量表的研制:日常生活活动呼吸困难量表
Respirology. 2009 Apr;14(3):429-35. doi: 10.1111/j.1440-1843.2009.01479.x. Epub 2009 Feb 4.
8
Factor analysis of exercise capacity, dyspnoea ratings and lung function in patients with severe COPD.重度慢性阻塞性肺疾病患者运动能力、呼吸困难评分及肺功能的因子分析
Eur Respir J. 1994 Apr;7(4):725-9. doi: 10.1183/09031936.94.07040725.
9
Predictors of success and failure in pulmonary rehabilitation.肺康复治疗成败的预测因素。
Eur Respir J. 2006 Apr;27(4):788-94. doi: 10.1183/09031936.06.00130605. Epub 2006 Feb 15.
10
Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis.特发性肺纤维化患者残疾程度对肺康复反应的影响。
Respirology. 2011 Nov;16(8):1196-202. doi: 10.1111/j.1440-1843.2011.02029.x.

引用本文的文献

1
Sex-Based Disparities in Clinical Burden and Diagnostic Delay in COPD: Insights from Primary Care.慢性阻塞性肺疾病临床负担和诊断延迟中的性别差异:来自初级保健的见解
J Clin Med. 2025 Sep 4;14(17):6258. doi: 10.3390/jcm14176258.
2
Decoding Diagnostic Delay in COPD: An Integrative Analysis of Missed Opportunities, Clinical Risk Profiles, and Targeted Detection Strategies in Primary Care.解读慢性阻塞性肺疾病的诊断延迟:对基层医疗中错失的机会、临床风险概况及靶向检测策略的综合分析
Diagnostics (Basel). 2025 Aug 30;15(17):2209. doi: 10.3390/diagnostics15172209.
3
Respiratory Rehabilitation Index (R2I): Unsupervised Clustering Approach to Identify COPD Subgroups Associated with Rehabilitation Outcomes.呼吸康复指数(R2I):用于识别与康复结果相关的慢性阻塞性肺疾病亚组的无监督聚类方法。
Diagnostics (Basel). 2025 Aug 16;15(16):2053. doi: 10.3390/diagnostics15162053.
4
Long-term effects of face-to-face supervision versus telephone supervision during a community-based pulmonary rehabilitation programme in people with COPD using minimal equipment: a randomized controlled trial.在慢性阻塞性肺疾病患者中使用最少设备进行社区肺康复计划时,面对面监督与电话监督的长期效果:一项随机对照试验。
BMC Prim Care. 2025 Aug 27;26(1):268. doi: 10.1186/s12875-025-02962-3.
5
Comparison of Telehealth and Onsite Supervised Maintenance Exercise Programs for Adults With Chronic Lung Disease: Protocol for a Pilot Randomized Feasibility Trial.远程医疗与现场监督的慢性肺病成人维持运动计划的比较:一项试点随机可行性试验方案
JMIR Res Protoc. 2025 Aug 25;14:e71039. doi: 10.2196/71039.
6
Association between nutritional risk and clinical outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期患者营养风险与临床结局的相关性
Am J Transl Res. 2025 Jul 25;17(7):5746-5756. doi: 10.62347/MCZH5861. eCollection 2025.
7
Risk factors for mortality in Finnish bronchiectasis patients: A four-year study.芬兰支气管扩张症患者的死亡风险因素:一项为期四年的研究。
Chron Respir Dis. 2025 Jan-Dec;22:14799731251358596. doi: 10.1177/14799731251358596. Epub 2025 Aug 17.
8
Virtual post-COVID-19 clinics in Saudi Arabia: navigating the effect of the pandemic with a national project.沙特阿拉伯的新冠疫情后虚拟诊所:通过一个国家项目应对疫情的影响
Front Public Health. 2025 Jul 30;13:1460324. doi: 10.3389/fpubh.2025.1460324. eCollection 2025.
9
Increased Incidence of Chronic Obstructive Pulmonary Disease in Women Due to Long-Term Passive Smoking.长期被动吸烟导致女性慢性阻塞性肺疾病发病率上升。
Int J Chron Obstruct Pulmon Dis. 2025 Aug 7;20:2745-2752. doi: 10.2147/COPD.S534060. eCollection 2025.
10
BREATHEIN: Better understanding obstructive REspiratory Airway disease Treatment and HEalth: a nationwide INvestigative survey in Denmark-a study protocol.BREATHEIN:更好地理解阻塞性呼吸道疾病的治疗与健康:丹麦的一项全国性调查研究方案
BMJ Open. 2025 Aug 6;15(8):e099447. doi: 10.1136/bmjopen-2025-099447.

本文引用的文献

1
Quality of life changes in COPD patients treated with salmeterol.使用沙美特罗治疗的慢性阻塞性肺疾病患者的生活质量变化
Am J Respir Crit Care Med. 1997 Apr;155(4):1283-9. doi: 10.1164/ajrccm.155.4.9105068.
2
Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society.肺容量与用力通气流量。欧洲煤钢共同体肺功能测试标准化工作小组报告。欧洲呼吸学会官方声明。
Eur Respir J Suppl. 1993 Mar;16:5-40.
3
Arterialised earlobe blood gas analysis: an underused technique.动脉化耳垂血气分析:一项未得到充分利用的技术。
Thorax. 1994 Apr;49(4):364-6. doi: 10.1136/thx.49.4.364.
4
The perception of breathlessness in asthma.哮喘中呼吸急促的感知
Am Rev Respir Dis. 1982 Nov;126(5):825-8. doi: 10.1164/arrd.1982.126.5.825.
5
The hospital anxiety and depression scale.医院焦虑抑郁量表。
Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
6
Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis.态度和信念对慢性支气管炎运动耐量的影响。
Br Med J (Clin Res Ed). 1983 Jan 15;286(6360):171-3. doi: 10.1136/bmj.286.6360.171.
7
A measure of quality of life for clinical trials in chronic lung disease.慢性肺病临床试验的生活质量衡量指标。
Thorax. 1987 Oct;42(10):773-8. doi: 10.1136/thx.42.10.773.
8
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.慢性气流受限健康状况的一种自我完备测量方法。圣乔治呼吸问卷。
Am Rev Respir Dis. 1992 Jun;145(6):1321-7. doi: 10.1164/ajrccm/145.6.1321.
9
The Extended Activities of Daily Living scale: a further validation.日常生活扩展活动量表:进一步验证
Disabil Rehabil. 1992 Jan-Mar;14(1):41-3. doi: 10.3109/09638289209166426.
10
Development of a shuttle walking test of disability in patients with chronic airways obstruction.慢性气道阻塞患者残疾程度的穿梭步行试验的开发。
Thorax. 1992 Dec;47(12):1019-24. doi: 10.1136/thx.47.12.1019.

医学研究委员会(MRC)呼吸困难量表在评估慢性阻塞性肺疾病患者残疾程度方面的实用性。

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

作者信息

Bestall J C, Paul E A, Garrod R, Garnham R, Jones P W, Wedzicha J A

机构信息

Division of Physiological Medicine, St George's Hospital Medical School, London SW17 0RE, UK.

出版信息

Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581.

DOI:10.1136/thx.54.7.581
PMID:10377201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1745516/
Abstract

BACKGROUND

Methods of classifying chronic obstructive pulmonary disease (COPD) depend largely upon spirometric measurements but disability is only weakly related to measurements of lung function. With the increased use of pulmonary rehabilitation, a need has been identified for a simple and standardised method of categorising disability in COPD. This study examined the validity of the Medical Research Council (MRC) dyspnoea scale for this purpose.

METHODS

One hundred patients with COPD were recruited from an outpatient pulmonary rehabilitation programme. Assessments included the MRC dyspnoea scale, spirometric tests, blood gas tensions, a shuttle walking test, and Borg scores for perceived breathlessness before and after exercise. Health status was assessed using the St George's Respiratory Questionnaire (SGRQ) and Chronic Respiratory Questionnaire (CRQ). The Nottingham Extended Activities of Daily Living (EADL) score and Hospital Anxiety and Depression (HAD) score were also measured.

RESULTS

Of the patients studied, 32 were classified as having MRC grade 3 dyspnoea, 34 MRC grade 4 dyspnoea, and 34 MRC grade 5 dyspnoea. Patients with MRC grades 1 and 2 dyspnoea were not included in the study. There was a significant association between MRC grade and shuttle distance, SGRQ and CRQ scores, mood state and EADL. Forced expiratory volume in one second (FEV1) was not associated with MRC grade. Multiple logistic regression showed that the determinants of disability appeared to vary with the level of disability. Between MRC grades 3 and 4 the significant covariates were exercise performance, SGRQ and depression score, whilst between grades 4 and 5 exercise performance and age were the major determinants.

CONCLUSIONS

The MRC dyspnoea scale is a simple and valid method of categorising patients with COPD in terms of their disability that could be used to complement FEV1 in the classification of COPD severity.

摘要

背景

慢性阻塞性肺疾病(COPD)的分类方法很大程度上依赖于肺功能测定,但残疾程度与肺功能测量的相关性较弱。随着肺康复治疗的使用增加,人们发现需要一种简单且标准化的方法来对COPD患者的残疾程度进行分类。本研究旨在检验医学研究委员会(MRC)呼吸困难量表在此方面的有效性。

方法

从门诊肺康复项目中招募了100例COPD患者。评估内容包括MRC呼吸困难量表、肺功能测试、血气张力、往返步行试验以及运动前后的Borg呼吸困难评分。使用圣乔治呼吸问卷(SGRQ)和慢性呼吸问卷(CRQ)评估健康状况。还测量了诺丁汉扩展日常生活活动(EADL)评分和医院焦虑抑郁(HAD)评分。

结果

在研究的患者中,32例被分类为MRC 3级呼吸困难,34例为MRC 4级呼吸困难,34例为MRC 5级呼吸困难。MRC 1级和2级呼吸困难的患者未纳入本研究。MRC分级与往返距离、SGRQ和CRQ评分、情绪状态及EADL之间存在显著关联。一秒用力呼气容积(FEV1)与MRC分级无关。多元逻辑回归显示,残疾的决定因素似乎因残疾程度而异。在MRC 3级和4级之间,显著的协变量是运动表现、SGRQ和抑郁评分,而在4级和5级之间,运动表现和年龄是主要决定因素。

结论

MRC呼吸困难量表是一种简单有效的对COPD患者残疾程度进行分类的方法,可用于补充FEV1以对COPD严重程度进行分类。